Login / Signup

The feasibility and acceptability of collecting psychosocial outcome measures embedded within a precision medicine trial for childhood cancer.

Eden G RobertsonKate HetheringtonRebecca DalyMark W DonoghoeNicholas HandelsmanDavid S ZieglerClaire E Wakefield
Published in: Cancer medicine (2024)
PRISM-Impact response rates were comparable to other psycho-oncology studies, despite the poor prognosis population. Integration of PROMs within a paediatric oncology trial is acceptable to parents, and may provide a more comprehensive assessment of the impact of trial participation.
Keyphrases
  • poor prognosis
  • phase iii
  • study protocol
  • phase ii
  • childhood cancer
  • clinical trial
  • long non coding rna
  • palliative care
  • patient reported outcomes
  • randomized controlled trial
  • young adults
  • physical activity
  • open label